How Myriad Genetics helped address the gap in genetic testing among women
Myriad Genetics and agency partner S50 Health educated OBGYNs and their patients in a campaign called “Getting Ahead of ...
联合健康限制Myriad的GeneSight测试的保险覆盖范围
盐湖城 - 专门从事基因测试和精准医疗的Myriad Genetics, Inc. (NASDAQ: MYGN)宣布对联合健康最近的政策更新表示不同意。该保险公司计划从2025年1月1日起，在其商业和个人交换福利计划下限制多基因组药物基因组学测试的覆盖范围，包括Myriad的GeneSight测试。 这一政策变更于周五传达给Myriad，公司对此表示惊讶和失望。Myriad的总裁兼首席执行官Pau ...
Myriad Genetics股票目标价在联合健康更新后保持不变
周一，TD Cowen维持Myriad Genetics (NASDAQ:MYGN)股票的持有评级，目标价保持在$30.00不变。这一决定是在联合健康(UNH)最近更改药物基因检测政策之后做出的。 具体而言，UNH更新了其指南，排除了对多基因检测的覆盖，包括Myriad Genetics的GeneSight产品，该产品用于指导抗抑郁药物治疗。在这一公告之后，Myriad Genetics的股价下跌 ...
Indulgexpress on MSN10 小时
Myriad threads converge to turn designer Richa Khemka's collection so stunning
Versatile designer Richa Khemka's newly unveiled collection Piecing Art Together is all about rich textures and fabrics in a ...
Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage
Myriad Genetics stock plunges after UnitedHealth Group announces they will no longer cover genetic tests for mental health ...
Myriad Genetics in Active Talks with UnitedHealthcare to Keep Coverage of GeneSight
Myriad Genetics said it is in talks with UnitedHealthcare to ensure that enrollees continue to have access to its GeneSight mental health medication test after the insurer changed its coverage policy.
Myriad Genetics Shares Slip 21% on UnitedHealthcare Coverage Changes
Myriad Genetics stock was down 21%, to $17.30, in midday Friday trading. Shares of the diagnostic-test maker have fallen 34% over the past month. Starting Jan. 1, the UnitedHealth Group unit plans to ...